SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

GUJARAT THEMIS BIOSYN

BSE: 506879 09 Sep 2025
Healthcare
₹ 380.2
Gujarat Themis Biosyn Ltd. specializes in Pharmaceuticals within the Healthcare sector.

GUJARAT THEMIS BIOSYN - Share Price & Details

Market Cap
₹4,188
High /Low
411.0 / 192.0
Stock P/E
93.9
Book Value
₹22.8
Dividend Yield
0.17
ROCE
27.3
ROE
₹21.7
Face Value
1.0
PEG Ratio
24.8
EVEBITDA
₹63.4
Debt
30.5
CMP / FCF
-636.0
Debt to equity
₹0.12
NP Ann
48.8
High price all time
411.0
Piotroski score
₹4.0
Graham Number
45.8
No. Eq. Shares
10.9
Net CF
₹5.22
Net profit
44.6
Price to book value
16.9
Interest Coverage
₹182.0
Low price all time
0.59
Industry PE
33.4
Reserves
₹237
Free Cash Flow
₹-25.1

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
FABINO ENTERPRISES LIMITEDNANANANA5.4691.0
Triochem Products Ltd.,NANANANA0
GUJARAT THEMIS BIOSYN LTD.361.4790.62358.730.834,18893.9
RPG LIFE SCIENCES LTD.1741.5262.91689.20393138.0
Advanced Enzyme Technologies L1788.76739.811250.246.61387128.3

Peer Comparison Chart


About GUJARAT THEMIS BIOSYN

Gujarat Themis Biosyn Ltd., with Security Code 506879, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Gujarat Themis Biosyn Achieves 52-Week High Amid Strong Market Performance

(25 Aug 2025)
Gujarat Themis Biosyn's stock has reached a new 52-week high of Rs. 405, following a strong six-day performance with a 15.01% gain.
Read more →

Gujarat Themis Biosyn Stock Reaches All-Time High, Signaling Strong Market Confidence

(25 Aug 2025)
Gujarat Themis Biosyn's stock reached an all-time high of Rs. 405, reflecting strong performance in the small-cap pharmaceutical sector.
Read more →

Gujarat Themis Biosyn Ltd Announces 44th AGM and Releases Annual Report

(20 Aug 2025)
The latest update is out from Gujarat Themis Biosyn Ltd ( ($IN:GUJTHEM) ). Gujarat Themis Biosyn Ltd has announced the scheduling of its...
Read more →

Gujarat Themis Biosyn - 11 FII-backed smallcaps post robust profit margins for four consecutive quarters

(19 Aug 2025)
FY26 YTD Performance: Up 29% from Rs 282 to Rs 362Profit Margins (Sep'24–Jun'25): 30% → 33% → 32% → 25%FII Holdings: Mar'25: 1.91% | Jun'25:...
Read more →

Gujarat Themis Biosyn Ltd Publishes Q1 2025 Financial Results

(02 Aug 2025)
The latest update is out from Gujarat Themis Biosyn Ltd ( ($IN:GUJTHEM) ). Gujarat Themis Biosyn Ltd has announced the publication of its...
Read more →

Gujarat Themis Biosyn Achieves All-Time High, Signaling Strong Market Momentum

(02 Aug 2025)
Gujarat Themis Biosyn has reached an all-time high stock price of Rs. 398, reflecting strong performance in the Pharmaceuticals...
Read more →

Company Updates